Las Vegas, NV -- (ReleaseWire) -- 08/30/2018 --A new market study, titled "Global Transthyretin Amyloidosis (ATTR) Market – Estimation & Forecast, 2014-2025", has been featured on CrystalMarketResearch.
Industry Outlook:
The Transthyretin Amyloidosis (ATTR) Market is anticipated to grow tremendously over the forecast period. Transthyretin (TTR) amyloidosis is a medical condition portrayed by the development of irregular deposits of a protein called amyloid (amyloidosis) in a body's organs and tissues. It commonly influences the cardiovascular system and peripheral neuropathic or autonomic neuropathy system. The cardiovascular type of Transthyretin (TTR) amyloidosis brings about the risk of cardiomegaly, arrhythmia and orthostatic hypertension in patients. The worldwide ATTR market is anticipated to display a powerful development amid the conjecture time frame because of the likelihood of rising launches of ATTR therapeutic drugs, expanding African-American populace as they are hereditarily vulnerable to amyloidosis, expanding healthcare awareness among individuals, and increasing average income of people. Nonetheless, the development of this market can be impeded by stringent administrative schemes, the rising expense of ATTR drugs and inaccurate analysis of ATTR disorders and confinements of clinical trials.
Request Sample for In depth Analysis and Forecast at: https://www.crystalmarketresearch.com/report-sample/HC081225 .
Competitive Analysis:
The leading players in the market are;
Merck & Co
Corino Therapeutics Inc
Proclara Biosciences
Pfizer
Arcturus Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
(Early buyers will receive 10% customization on this report.)
Place a purchase order of this report at: https://www.crystalmarketresearch.com/checkout/HC081225 .
Market Segmentation:
The Transthyretin Amyloidosis (ATTR) market is based on different segments namely by disease the market is segmented into transthyretin (ttr) familial amyloid cardiomyopathy, transthyretin (ttr) familial amyloid polyneuropathy, and others; by treatment the market is segmented into rnai therapy, small molecules treatment, organ transplantation and others; by end-user the market is segment into ambulatory surgical centers, hospitals and clinics and others.
Market Classification:
Transthyretin Amyloidosis (ATTR) Market, By Disease, Estimates and Forecast, 2014-2025 ($Billion)
o Transthyretin (TTR) Familial Amyloid Cardiomyopathy
o Transthyretin (TTR) Familial Amyloid Polyneuropathy
o Others
Transthyretin Amyloidosis (ATTR) Market, By Treatment, Estimates and Forecast, 2014-2025 ($Billion)
o RNAi Therapy
o Small Molecules Treatment
o Organ Transplantation
o Others
Transthyretin Amyloidosis (ATTR) Market, By End User, Estimates and Forecast, 2014-2025 ($Billion)
o Ambulatory Surgical Centers
o Hospitals And Clinics
o Others
For more details send an inquiry at: https://www.crystalmarketresearch.com/send-an-enquiry/HC081225 .
Regional Insights:
On a global front, the Transthyretin Amyloidosis (ATTR) Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). The Americas command the market for Transthyretin (TTR) amyloidosis due to the rising prevalence of amyloidosis among adults and elderly population and increasing geriatric population which is a significant trigger factor for this disease.
Major ToC of Transthyretin Amyloidosis (ATTR) Market:
Chapter 1. Introduction
Chapter 2. Executive Summary
Chapter 3. Market Overview
Chapter 4. Market Analysis by Regions
Chapter 5. Transthyretin Amyloidosis (ATTR) Market, By Disease
Chapter 6. Transthyretin Amyloidosis (ATTR) Market, By Treatment
Chapter 7. Transthyretin Amyloidosis (ATTR) Market, By End-User
Chapter 8. Transthyretin Amyloidosis (ATTR) Market, By Region
Chapter 9. Company Profiles
Chapter 10. Global Transthyretin Amyloidosis (ATTR) Market Competition, by Manufacturer
Chapter 11. Transthyretin Amyloidosis (ATTR) Market Forecast (2018-2025)
List of Tables and Figures:
Figure United States Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Transthyretin Amyloidosis (ATTR) Revenue and Revenue Share by Disease (2014-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue and Revenue Share by Treatment (2014-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue and Revenue Share by End-User (2014-2018)
Table Global Transthyretin Amyloidosis (ATTR) Revenue by Regions (2014-2018)
Table Merck & Co Transthyretin Amyloidosis (ATTR) Price, Revenue, Gross Margin and Market Share (2016-2017)
…Read Full Table of Contents
Request Attractive Discount on the report at: https://www.crystalmarketresearch.com/check-discount/HC081225 .
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contacts Us
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: sales@crystalmarketresearch.com | Ph: +1-888-213-4282
Web: https://www.crystalmarketresearch.com
